Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapTel (Captioned Telephone) is a leading provider of assistive telecommunications technology designed for individuals with hearing loss. The company's primary product is the CapTel captioned telephone, which displays real-time text captions of everything a caller says, allowing users to listen while reading the conversation. CapTel services are provided through a network of captioning centers and are often funded through the Americans with Disabilities Act (ADA) as part of the Telecommunications Relay Service (TRS). The technology utilizes advanced voice recognition and human captioning assistants to ensure accuracy and speed. CapTel is a division of Ultratec, a pioneer in text telecommunications for the deaf and hard of hearing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapTel.